These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31722998)

  • 1. Novel Mechanisms of Cancer Emerge When Accounting for Sex as a Biological Variable.
    Wilson MA; Buetow KH
    Cancer Res; 2020 Jan; 80(1):27-29. PubMed ID: 31722998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics and Epigenetics of Sex Bias: Insights from Human Cancer and Autoimmunity.
    Credendino SC; Neumayer C; Cantone I
    Trends Genet; 2020 Sep; 36(9):650-663. PubMed ID: 32736810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
    Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating Sex as a Variable in Preclinical Neuropsychiatric Research.
    McCarthy MM
    Schizophr Bull; 2015 Sep; 41(5):1016-20. PubMed ID: 26067001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considering Sex as a Biological Variable Will Be Valuable for Neuroscience Research.
    Shansky RM; Woolley CS
    J Neurosci; 2016 Nov; 36(47):11817-11822. PubMed ID: 27881768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology in the era of "Personalized Medicine": The need to learn how to integrate multivariate immunohistochemical and "omics" data with clinicopathologic information in a clinically relevant way".
    Marchevsky AM; Walts AE; Wick MR
    Ann Diagn Pathol; 2019 Dec; 43():151410. PubMed ID: 31689574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special series on comparative effectiveness research: challenges to real-world solutions to quality improvement in personalized medicine.
    Browman GP
    J Clin Oncol; 2012 Dec; 30(34):4188-91. PubMed ID: 23071250
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex Differences Research, Precision Medicine, and the Future of Women's Health.
    Miller VM; Rocca WA; Faubion SS
    J Womens Health (Larchmt); 2015 Dec; 24(12):969-71. PubMed ID: 26325362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Getting more grip on genetic risk prediction studies: the GRIPS statement.
    Knottnerus JA; Tugwell P
    J Clin Epidemiol; 2011 Aug; 64(8):817-8. PubMed ID: 21704255
    [No Abstract]   [Full Text] [Related]  

  • 12. Methods for prospectively incorporating gender into health sciences research.
    Tadiri CP; Raparelli V; Abrahamowicz M; Kautzy-Willer A; Kublickiene K; Herrero MT; Norris CM; Pilote L;
    J Clin Epidemiol; 2021 Jan; 129():191-197. PubMed ID: 32980428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining precision medicine.
    Burki TK
    Lancet Oncol; 2017 Dec; 18(12):e719. PubMed ID: 29153736
    [No Abstract]   [Full Text] [Related]  

  • 14. Test of Hardy-Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions.
    Yu KD; Di GH; Fan L; Shao ZM
    Breast Cancer Res Treat; 2009 Oct; 117(3):675-7. PubMed ID: 19242790
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrated patient and tumor genetic testing for individualized cancer therapy.
    Hertz DL; McLeod HL
    Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.
    Bristow RG; Alexander B; Baumann M; Bratman SV; Brown JM; Camphausen K; Choyke P; Citrin D; Contessa JN; Dicker A; Kirsch DG; Krause M; Le QT; Milosevic M; Morris ZS; Sarkaria JN; Sondel PM; Tran PT; Wilson GD; Willers H; Wong RKS; Harari PM
    Lancet Oncol; 2018 May; 19(5):e240-e251. PubMed ID: 29726389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: Personalized medicine: what is it and what are the challenges?
    Sigman M
    Fertil Steril; 2018 Jun; 109(6):944-945. PubMed ID: 29935651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steps forward for cancer precision medicine.
    Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
    Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine Requires Precision Laboratories.
    Rajeevan MS; Li T; Unger ER
    J Mol Diagn; 2017 Mar; 19(2):226-229. PubMed ID: 28130021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.